Prostate Cancer - Results from #2580

Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval June 21, 2023

Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center. June 21, 2023

Liver fibrosis scores and prostate cancer risk and mortality in the Atherosclerosis Risk in Communities (ARIC) Study. June 21, 2023

Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case-control study. June 21, 2023

Efficacy of Systemic Treatment in Prostate Cancer Patients with Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis. June 21, 2023

A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer. June 21, 2023

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors. June 21, 2023

Immune mechanisms shape the clonal landscape during early progression of prostate cancer. June 21, 2023

CXCR7 as a novel therapeutic target for advanced prostate cancer. June 21, 2023

The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery. June 21, 2023

The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. June 21, 2023

Fragmentomic analysis of circulating tumor DNA targeted cancer panels. June 21, 2023

Blue Earth Therapeutics Highlights Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting June 20, 2023

Cardiovascular Safety of Testosterone-Replacement Therapy June 20, 2023

PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection. June 20, 2023

Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey. June 20, 2023

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator. June 20, 2023

Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla. June 20, 2023

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer. June 20, 2023

Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images. June 20, 2023

Page 130 of 1439